學術研究成果/Publication
基本資料/Profiles
姓名/Name: 黃升騰 性別/Gender:
英文姓名/
English Name:
Sheng-Teng Huang 英文縮寫/
Abbreviation:
任職單位/
Affiliation:
1.中醫學院中醫學系學士班中醫內科學科(教授) / School of Chinese Medicine- Internal Medicine (Professor)
2.中國附醫中醫內科(部主任) / Division of Chinese Internal Medicine (Director-General)
3.安南醫院安南中醫部(部主任) / (Director-General)
Email: sthuang@mail.cmu.edu.tw
研究專長/Fields of Specialty
1﹒ 中醫藥
2﹒ 針灸
3﹒ 分子生物
4﹒ 臨床試驗
5﹒ Cancer molecular biology
6﹒ Chinese medicine
 
期刊論文/Journal Paper
(作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
SCI論文 歐世宸(Shi-Chen Ou)、林美辰(Mei-Chen Lin)、林宏任(Hung-jen Lin)、黃志平(Chi-Ping Huang)、黃升騰(Sheng-Teng Huang)*,Association between erectile dysfunction and fibromyalgia in male patients: A Taiwanese nationwide population-based cohort study,INTERNATIONAL JOURNAL OF UROLOGY,2020 Sep,2020():
SCI論文 鄭惟仁(Wei-Zen Cheng)、林筠嵐(Lin Yun-Lan)、蘇元智(Su Yuan-Chih)、林美辰(Mei-Chen Lin)、曾政興(Tseng Chang-Hsing)、林瑞模(Ruey-Mo Lin)、黃升騰(Sheng-Teng Huang)*,Post‑surgery cholecystectomy, hepatectomy, and pancreatectomy patients increase the risk of osteoporotic vertebral fracture,JOURNAL OF BONE AND MINERAL METABOLISM,2020 Aug,2020():
SCI論文 許碩珉(Hsu, Sheng-Min)、林宏任(Hung-jen Lin)、林美辰(Mei-Chen Lin)、黃升騰(Sheng-Teng Huang)*,Increased incidence and recurrence rates of acute diverticulitis in patients with irritable bowel syndrome,Colorectal Disease,2020 Aug,2020():
SCI論文 黃升騰(Sheng-Teng Huang)、賴香君(Hsiang-Chun Lai)、林幼淳(Yu-Chun Lin)、黃維德(Wei-Te Huang)、洪皓脩(Hao-Hsiu Hung)、歐世宸(Shi-Chen Ou)、林宏任(Hung-jen Lin)、洪明奇(Mien-Chie Hung)*,Principles and treatment strategies for the use of Chinese herbal medicine in patients at different stages of coronavirus infection,American Journal of Cancer Research,2020 Jul,10(7):2010-2031
SCI論文 賴香君(Hsiang-Chun Lai)、林宏任(Hung-jen Lin)、高翊偉(Kao Yi-Wei)、汪開勛(Wang Kai-Hsun)、周仁偉(Jen-Wei Chou)、謝邦昌(Shia Ben-Chang)、黃升騰(Sheng-Teng Huang)*,Irritable bowel syndrome increases the risk of chronic obstructive pulmonary disease: A retrospective cohort study,Scientific Reports,2020 Jun,10(1):10008
SCI論文 黃維德(Wei-Te Huang)、洪皓脩(Hao-Hsiu Hung)、高翊偉(Kao Yi-Wei)、歐世宸(Ou Shi Chen)、林于娟(Ling yu chuan)、鄭惟仁(Wei-Zen Cheng)、顏子榮(Yen Zi-Rong)、李艦(Li Jian)、陳銘芷(Chen Ming-Chih)、謝邦昌(Shia Ben-Chang)*、黃升騰(Sheng-Teng Huang)*,Application of Neural Network and Cluster Analyses to Differentiate TCM Patterns in Patients With Breast Cancer,Frontiers in Pharmacology,2020 May,11():670
SCI論文 張正杰(Chang, Cheng-Chieh)、尤慧玲(You Huey-Ling)、黃升騰(Sheng-Teng Huang)*,Catechin inhibiting the H1N1 influenza virus associated with the regulation of autophagy.,Journal of the Chinese Medical Association,2020 Apr,83(4):386-393
SCI論文 盧漢霖(Lu, Han-Lin)、蘇元智(Su, Yuan-Chih)、林美辰(Mei-Chen Lin)、孫茂峰(Mao-Feng Sun)、黃升騰(Sheng-Teng Huang)*,Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study,COMPLEMENTARY THERAPIES IN MEDICINE,2020 Mar,49():102332
SCI論文 林幼淳(Yu-Chun Lin)、黃超俊(Huang, Chao-Chun)、林美辰(Mei-Chen Lin)、黃升騰(Sheng-Teng Huang)*,Chinese herbal medicine reduces the risk of urinary incontinence in patients with chronic obstructive pulmonary disease: A populationbased retrospective cohort study,INTERNATIONAL JOURNAL OF UROLOGY,2020 Mar,2020():
SCI論文 張哲彬(Che-Pin Chang)、蘇元智(Yuan-Chih Su)、林美辰(Lin, Mei-Chen)、黃升騰(Sheng-Teng Huang)*,Chinese herbal medicine ameliorated the development of chronic kidney disease in patients with chronic hepatitis C - A retrospective population-based cohort study,Evidence-based Complementary and Alternative Medicine,2019 Oct,():
SCI論文 林祖功(Lin Tsu-Kung)、張永義(Chang Yung-Yee)、林宏昱(Lin Hung-Yu)、劉嘉為(Liou Chia-Wei)、王佩文(Wang Pei-Wen)、莊錦豪(Chuang Jiin-Haur)、陳尚德(Chen Shang-Der)、莊曜聰(Chuang Yao-Chung)、黃升騰(Sheng-Teng Huang)、許德耀(Hsu Te-Yao)、(Peng Cheng-Huei)、藍旻瑜(Lan Min-Yu)*,Mitochondrial dysfunctions in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL),PLoS One,2019 Oct,14(10):
SCI論文 林彩蕙(Tsai-Hui Lin)、陳書怡(Shu-I Chen)、蘇圓智(Su Yuan-Chih)、林美辰(Mei-Chen Lin)、林宏任(Hung-jen Lin)、黃升騰(Sheng-Teng Huang)*,Conventional Western Treatment Combined With Chinese Herbal Medicine Alleviates the Progressive Risk of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study,Frontiers in Pharmacology,2019 Sep,10():987
SCI論文 黃升騰(Sheng-Teng Huang)*、許偉帆(Wei-Fan Hsu)、黃紘森(Huang Hung-Sen)、顏加豪(Jia-hau Yen)、林美辰(Mei-Chen Lin)、彭成元(Cheng-Yuan Peng)、顏宏融(Hung-Rong Yen)*,Improved Survival in Hepatocellular Carcinoma Patients with Cardiac Arrhythmia by Amiodarone Treatment through Autophagy,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2019 Aug,20(16):3978
SCI論文 林祖功(Lin Tsu-Kung)、陳尚德(Chen Shang-Der)、莊曜聰(Chuang Yao-Chung)、藍旻瑜(Lan Min-yu)、莊錦豪(Chuang Jiin-Haur)、王佩文(Wang Pei-Wen)、許德耀(Hsu Te-Yao)、王逢興(Wang Feng-Sheng)、蔡孟翰(Tsai Meng-Han)、黃升騰(Sheng-Teng Huang)、王筱玟(Wang Xiao-Wen)、蔡伯鑫(Tsai Po-Chin)、林宏昱(Lin Hung-Yu)、劉嘉為(Liou Chia-Wei)*,Mitochondrial Transfer of Wharton’s Jelly Mesenchymal Stem Cells Eliminates Mutation Burden and Rescues Mitochondrial Bioenergetics in Rotenone-Stressed MELAS Fibroblasts,Oxidative Medicine and Cellular Longevity,2019 May,2019():9537504-9537521
SCI論文 張家禎(Chia-Chen Chang)、(Kuo-Wei Bi,)、林宏任(Hung-jen Lin)、王玟玲(Wen-Ling Wang)、林振源(Lin, Chen-Yuan)、丁俊夫(Chun-Fu Ting)、孫茂峰(Mao-Feng Sun)、黃升騰(Sheng-Teng Huang)*,Conventional western treatment associated with Chinese herbal medicine ameliorates the incidence of head and neck cancer among patients with esophageal cancer,INTEGRATIVE CANCER THERAPIES,2019 Mar,18():
SCI論文 林于娟(Ling yu chuan)、黃維德(Wei-Te Huang)、歐世宸(Ou Shi Chen)、洪皓脩(Hao-Hsiu Hung)、鄭惟仁(Wei-Jen Cheng)、林聖興(Sheng-Shing Lin)、林宏任(Hung-jen Lin)、黃升騰(Sheng-Teng Huang)*,Neural network analysis of Chinese herbal medicine prescriptions for patients with colorectal cancer,COMPLEMENTARY THERAPIES IN MEDICINE,2019 Feb,42(2019):279-285
SCI論文 黃維德(Wei-Te Huang)、涂慶業(Chin-Yeh Tu)、王芬郁(Fen-Yu Wang)、黃升騰(Sheng-Teng Huang)*,Literature review of liver injury induced by Tinospora crispa associated with two cases of acute fulminant hepatitis,COMPLEMENTARY THERAPIES IN MEDICINE,2019 Feb,42(2019):286-291
SCI論文 江坤俊(Chiang Kun-Chun)、黃升騰(Sheng-Teng Huang)、吳仁欽(Wu Ren-Chin)、黃仁聖(Huang Shih-Chiang)、葉大森(Yeh Ta-Sen)、陳明晃(Chen Ming-Huang)、徐潤德(Hsu Jun-Te)、陳立偉(Chen Li-Wei)、郭昇鋒(Kuo Sheng-Fong)、闕河晏(Chueh Ho-Yen)、莊宏亨(Juang Horng-Heng)、洪舜郁(Hung Shuen-Lu)、葉俊男(Yeh Chun-Nan)*、蘇中慧(S. Pang Jong-Hwei),Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival,Cancer Management and Research,2019 Feb,2019():
SCI論文 顏加豪(Jia-hau Yen)、黃紘森(Huang Hung-Sen)、莊家如(CHUANG CHIA-JU)、黃升騰(Sheng-Teng Huang)*,Activation of dynamin-related protein 1-dependent mitochondria fragmentation and suppression of osteosarcoma by cryptotanshinone,JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2019 Jan,38(42):1-15
SCI論文 王禎佑(Chen-Yu Wang)、黃紘森(Huang Hung-Sen)、(Yuan-Chih Su)、涂智彥(Chih-Yen Tu)、夏德椿(Te-Chun Hsia)、黃升騰(Sheng-Teng Huang)*,Conventional treatment integrated with Chinese herbal medicine improves the survival rate of patients with advanced non-small cell lung cancer,COMPLEMENTARY THERAPIES IN MEDICINE,2018 Oct,40():29-36
SCI論文 黃國欽(Huang, Kuo-Chin)、(Yuan-Chih Su)、孫茂峰(Mao-Feng Sun)、黃升騰(Sheng-Teng Huang)*,Chinese Herbal Medicine Improves the Long-Term Survival Rate of Patients With Chronic Kidney Disease in Taiwan: A Nationwide Retrospective Population-Based Cohort Study.,Frontiers in Pharmacology,2018 Oct,9(1117):1-10
SCI論文 黃升騰(Sheng-Teng Huang)*、(Cheng-Chieh Chang)、(Jong-Hwei S. Pang)、(Hung-Sen Huang)、周聖杰(Shen-Chieh Chou)、高銘欽(Ming-Ching Kao)、(Huey-Ling You),Drynaria fortunei Promoted Angiogenesis Associated With Modified MMP-2/TIMP-2 Balance and Activation of VEGF Ligand/Receptors Expression,Frontiers in Pharmacology,2018 Sep,9():
SCI論文 顏加豪(Jia-hau Yen)、黃升騰(Sheng-Teng Huang)*、黃紘森(Huang Hung-Sen)、(Yi-Chin Fong)、(Yi-Ying Wu)、(Jen-Huai Chiang)、(Yuan-Chih Su),HGK-sestrin 2 signaling-mediated autophagy contributes to antitumor efficacy of Tanshinone IIA in human osteosarcoma cells,Cell Death & Disease,2018 Sep,2018(9):1003-1019
SCI論文 陳暐棣(Wei-Di Chen)、黃紘森(Huang Hung-Sen)、(Yuan-Chih Su)、周聖杰(Shen-Chieh Chou)、何文照、高銘欽(Ming-Ching Kao)、林宏任(Hung-jen Lin)、黃升騰(Sheng-Teng Huang)*,The characteristics and prescription patterns of Chinese herbal medicine in clinical practice for the treatment of anemia,Taiwanese Journal of Obstetrics & Gynecology,2018 Aug,54(7):570-577
SCI論文 尤慧玲(Huey-Ling You)、(Chao Chun Huang)、(Chung-Jen Chen)、(Cheng-Chin Chang)、(Pei-Lin Liao)、黃升騰(Huang, Sheng-Teng)*,Anti-pandemic influenza A (H1N1) virus potential of catechin and gallic acid,Journal of the Chinese Medical Association,2018 May,81(5):458-468
SCI論文 李俐雯(Li-Wen Lee)、林宏任(Lin, Hung-Jen)、黃升騰(Huang, Sheng-Teng)*,Management of IFN-beta-induced flu-like symptoms with Chinese herbal medicine in a patient with multiple sclerosis: A case report,COMPLEMENTARY THERAPIES IN MEDICINE,2018 Jan,36(2018):123-128
SCI論文 賴香君(Lai, Hsiang-Chun)、林宏任(Lin, Hung-Jen)、黃升騰(Huang, Sheng-Teng)*,Chinese herbal medicine to treat urolithiasis in a patient with right flank pain and hematuria: A case report,COMPLEMENTARY THERAPIES IN MEDICINE,2017 Dec,36():
SCI論文 黃國欽(Huang, kuo-Chin)、顏宏融(Yen, Hung-Rong)、蔣仁槐(Chiang, Jen-Huai)、(Yuan-Chih Su)、孫茂峰(Sun, Mao-Feng)、張恒鴻(Chang, Hen-Hong)、黃升騰(Huang, Sheng-Teng)*,Chinese Herbal Medicine as an Adjunctive Therapy Ameliorated the Incidence of Chronic Hepatitis in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study,Evidence-based Complementary and Alternative Medicine,2017 Oct,2017(2017):1-9
SCI論文 (Jong-Hwei S. Pang)、顏加豪(Jia-hau Yen)、(Hsiao-Ting Wu)、黃升騰(Huang, Sheng-Teng)*,Gallic Acid Inhibited Matrix Invasion and AP-1/ETS-1-Mediated MMP-1 Transcription in Human Nasopharyngeal Carcinoma Cells,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2017 Jun,18(7):1354-1367
SCI論文 林彩蕙(Tsai-Hui Lin)、顏宏融(Hung-Rong Yen)、蔣仁槐(Chiang, Jen-Huai)、孫茂峰(SUN, MAO-FENG)、張恒鴻(CHANG,HEN-HONG)、黃升騰(Huang, Sheng-Teng)*,The use of Chinese herbal medicine as an adjuvant therapy to reduce incidence of chronic hepatitis in colon cancer patients: A Taiwanese population-based cohort study,JOURNAL OF ETHNOPHARMACOLOGY,2017 Apr,202():225-233
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Chao-Chun Huang)、黃紘森(Huang Hung-Sen)、(Tsu-Kung Lin)、(Pei-Lin Liao)、(Pei-Wen Wang)、(Chia-Wei Liou)、(Jiin-Haur Chuang),Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction,Scientific Reports,2017 Jan,7(40382):1-14
SCI論文 (Chun-Ting Liu)、(Kuo-Wei Bi)、(Chao-Chun Huang)、(Hsiao-Ting Wu)、(Hui-Ya Ho)、(Jong- Hwei S. Pang)*、黃升騰(Huang, Sheng-Teng)*,Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/ TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells,JOURNAL OF ETHNOPHARMACOLOGY,2017 ,196(2017):213-2016接受
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Chao-Chun Huang)、(Jer-Ming Sheen)、(Tsu-Kung Lin)、(Pei-Lin Liao)、黃紘森(Huang Hung-Sen)、(Pei-Wen Wang)、(Chia-Wei Liou)、(Jiin-Haur Chuang),Phyllanthus urinaria’s Inhibition of Human Osteosarcoma Xenografts Growth in Mice is Associated with Modulation of Mitochondrial Fission/Fusion Machinery,AMERICAN JOURNAL OF CHINESE MEDICINE,2016 Oct,44(7):1-17
SCI論文 (Woung-Ru Tang)*、(Sien-Hung Yang)、(Chih-Teng Yu)、(Chin-Chou Wang)、黃升騰(Huang, Sheng-Teng)、(Tzu-Hsin Huang)、(Ming-Chu Chiang)、(Yue-Cune Chang),Long-Term Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Lung Cancer,JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,2016 Mar,22(3):212-222
SCI論文 (Tun-Pin Hsueh)、(Jer-Ming Sheen)、(Jong-Hwei S. Pang)、(Kuo-Wei Bi)、(Chao-Chun Huang)、(Hsiao-Ting Wu)、黃升騰(Huang, Sheng-Teng)*,The Anti-Atherosclerotic Effect of Naringin Is Associated with Reduced Expressions of Cell Adhesion Molecules and Chemokines through NF-κB Pathway.,MOLECULES,2016 Feb,21(2):195
SCI論文 (Hsin-Ning Chang)、黃升騰(Huang, Sheng-Teng)、(Yuan-ChiehYeh)、(Hsin-ShihWang)、(Tzu-Hao Wang)、(Yi-Hong Wu)、(Jong-HweiS.Pang)*,Indigo naturalis and its component tryptanthrin exert anti-angiogenic effect by arresting cell cycle and inhibiting Akt and FAK signaling in human vascular endothelial cells,JOURNAL OF ETHNOPHARMACOLOGY,2015 Nov,4(174):474-481
SCI論文 (Hung-Yu Lin)、(Chia-Wei Liou)、(Shang-Der Chen)、(Te-Yao Hsu)、(Jiin-Haur Chuang)、(Pei-Wen Wang)、黃升騰(Huang, Sheng-Teng)、(Mao-Meng Tiao)、(Jin-Bor Chen)、(Tsu-Kung Lin)*、(Yao-Chung Chuang),Mitochondrial transfer fromWharton's jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function,MITOCHONDRION,2015 May,22():31-44
Other論文 黃博裕、吳清源、洪裕強、黃升騰(Huang, Sheng-Teng)、鄧雪妹、高照為、蔡明諺(Tsai, Ming-Yen)*,南臺灣偏遠地區中醫醫療服務滿意度及病患就診特性之研究,J Chin Med,2015 Jan,26(1):33-44
Other論文 鄭宇眞、沈哲民*、盧政男、黃升騰(Huang, Sheng-Teng),針藥併施治療偏頭痛經驗-病例報告,J Chin Med,2015 Jan,26(1):83-91
SCI論文 (Rong-Chi Yang)、(Cheng-Chieh Chang)、(Jer-Ming Sheen)、(Hsiao-Ting Wu)、(Jong-Hwei S. Pang)、黃升騰(Huang, Sheng-Teng)*,Davallia bilabiata Inhibits TNF-α-Induced Adhesion Molecules and Chemokines by Suppressing IKK/NF-kappa B Pathway in Vascular Endothelial Cells,AMERICAN JOURNAL OF CHINESE MEDICINE,2014 Dec,42(6):1-19
SCI論文 (Ming-Yen Tsai)、(Chun-Ting Liu)、(Cheng-Chieh Chang)、(Shih-Yu Chen)、黃升騰(Huang, Sheng-Teng)*,Overview of the relevant literature on the possible role of acupuncture in treating male sexual dysfunction,Acupuncture in Medicine,2014 Oct,32(5):406-410
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Kuo-Wei Bi)、(Hsiao-Mei Kuo)、(Tsu-Kung Lin)、(Pei-Lin Liao)、(Pei-WenWang)、(Jiin-Haur Chuang)、(Chia-Wei Liou),Phyllanthus urinaria induces mitochondrial dysfunction in human osteosarcoma 143B cells associated with modulation of mitochondrial fission/fusion proteins,MITOCHONDRION,2014 Jul,17():22-33
SCI論文 (Cheng-Chieh Chang)、(Chen-Fu Chu)、(Chao-Nin Wang)、(Hsiao-Ting Wu)、(Kuo-Wei Bi)、(Jong-Hwei S. Pang)*、黃升騰(Huang, Sheng-Teng)*,The anti-atherosclerotic effect of tanshinone IIA is associated with theinhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression,PHYTOMEDICINE,2014 Feb,21(3):207-216
SCI論文 (Tsu-Kung Lin)、(Shang-Der Chen)、(Yao-Chung Chuang)、(Hung-Yu Lin)、(Chi-Ren Huang)、(Jiin-Haur Chuang)、(Pei-Wen Wang)*、黃升騰(Huang, Sheng-Teng)、(Mao-Meng Tiao)、(Jin-Bor Chen)、(Chia-Wei Liou),Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2014 Jan,15(1):1625-1646
Other論文 薛敦品、蔡明諺、胡文龍、黃升騰(Huang, Sheng-Teng)、洪裕強*,中醫系學生執業考試與實習表現相關性評估-以南部某醫學中心為例,J Chin Med,2014 Jan,25(1):73-81
Other論文 鄭宇真、胡文龍、蔡明諺、黃升騰(Huang, Sheng-Teng)、陳志文、洪裕強*,南部某醫學中心中醫常見疾病與處方用藥探討,J Chin Med,2014 Jan,25(1):83-96
Other論文 沈哲民*、李冠東、黃升騰(Huang, Sheng-Teng)、盧政男、賴英秀(Lay Ing Shiow)、徐堅銘(HSU CHIEN MING)、何宗融(Tsung-Jung Ho),張仲景經方用藥一味差異影響治病範疇之研究,J Chin Med,2014 Jan,25(1):59-72
SCI論文 (Huey-Ling You)、(Chung-Jen Chen)、(Hock-Liew Eng)、(Pei-Lin Liao)、黃升騰(Huang, Sheng-Teng)*,The Effectiveness and Mechanism of Toona sinensis Extract Inhibit Attachment of Pandemic Influenza A (H1N1) Virus,Evidence-based Complementary and Alternative Medicine,2013 Jul,2013():1-12
SCI論文 (Tsu-Kung Lin)、(Hung-Yu Lin)、(Shang-Der Chen)、(Yao-Chung Chuang)、(Jiin-Haur Chuang)、(Pei-WenWang)、黃升騰(Huang, Sheng-Teng)、(Mao-Meng Tiao)、(Jin-Bor Chen)、(Chia-Wei Liou)*,The Creation of Cybrids Harboring Mitochondrial Haplogroups in the Taiwanese Population of Ethnic Chinese Background: An Extensive In Vitro Tool for the Study of Mitochondrial Genomic Variations,Oxidative Medicine and Cellular Longevity,2012 Oct,2012():1-13
Other論文 薛敦品、朱建福、黃升騰(Huang, Sheng-Teng)*,重症肌無力合併眼瞼下垂案例報告,J Chin Med,2012 Jul,24(1):167-174
SCI論文 (Jiin-Haur Chuang)、(Tsu-Kung Lin)、(Ming-Hong Tai)、(Chia-Wei Liou)、黃升騰(Huang, Sheng-Teng)、(Chia-Ling Wu)、(Hung-Yi Lin)、(Pei-Wen Wang)*,Preferential involvement of mitochondria in Toll-like receptor 3 agonist-induced neuroblastoma cell apoptosis, but not in inhibition of cell growth,APOPTOSIS,2012 Apr,17(4):335-348
SCI論文 (Hsin-Yi Wu)、(Tsu-Kung Lin)、(Hsiao-Mei Kuo)、(Ya-Ling Huang)、(Chia-Wei Liou)、(Pei-WenWang)、(Jiin-Haur Chuang)、黃升騰(Huang, Sheng-Teng)*,Phyllanthus urinaria Induces Apoptosis in Human Osteosarcoma 143B Cells via Activation of Fas/FasL- and Mitochondria-Mediated Pathways,Evidence-based Complementary and Alternative Medicine,2012 ,2012():1-13
SCI論文 (Ming-Yen Tsai)、(Rong-Chi Yang)、(Hsiao-Ting Wu)、(Jong-Hwei S. Pang)、黃升騰(Huang, Sheng-Teng)*,Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells,CANCER LETTERS,2011 Nov,310(2):198-206
SCI論文 (Hsei-Wei Wang)、(Kuo-Tong Liou)、(Yea-Hwey Wang)、(Chung-Kuang Lu)*、(Yun-Lian Lin)、(I-Jung Lee)、黃升騰(Huang, Sheng-Teng)、(Yuan-Hau Tsai)、(Yi-Chieh Cheng)、(Hung-Jui Lin)、(Yuh-Chiang Shen),Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice,JOURNAL OF ETHNOPHARMACOLOGY,2011 Oct,138(1):22-33
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Rong-Chi Yang)、(Hsiao-Ting Wu)、(Chao-Nin Wang)、(Jong-Hwei S. Pang),Zinc-Chelation Contributes to the Anti-Angiogenic Effect of Ellagic Acid on Inhibiting MMP-2 Activity, Cell Migration and Tube Formation,PLoS One,2011 May,6(5):e18986
Other論文 李冠東、黃升騰(Huang, Sheng-Teng)、(盧政男)、(洪裕強)、(沈哲民)*,胃食道逆流合併慢性胃炎中醫治療經驗-病例報告,J Chin Med,2011 Mar,22(3):231-237
SCI論文 (Cheng-Chieh Chang)、黃升騰(Huang, Sheng-Teng)*,Is Traditional Chinese medicine effective for reducing hyperthyroidism?,JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,2010 Nov,16(11):1217-1220
Other論文 林芸薇、黃升騰(Huang, Sheng-Teng)、(朱建福)*,小兒手術後腸沾黏之中醫治療經驗-案例報告,J Chin Med,2010 Oct,21(3):157-163
Other論文 黃升騰(Huang, Sheng-Teng)*、(Jong-Hwei S. Pang)、(Rong-Chi Yang),Anti-cancer effects of Phyllanthus urinaria and relevant mechanisms,Chang Gung Medical Journal,2010 Sep,33(5):477-487
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Chen-YuWang)、(Rong-ChiYang)、(Chih-JuChu)、(Hsiao-TingWu)、(Jong-HweiS.Pang),Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells,PHYTOMEDICINE,2010 Jan,17(1):47-54
SCI論文 黃升騰(Huang, Sheng-Teng)、(Chen-Yu Wang)、(Rong-Chi Yang)、(Hsiao-Ting Wu)、(Su-Hui Yang)、(Yung-Chi Cheng)、(Jong-Hwei S. Pang)*,Ellagic Acid, the Active Compound of Phyllanthus urinaria, Exerts In Vivo Anti-Angiogenic Effect and Inhibits MMP-2 Activity,Evidence-based Complementary and Alternative Medicine,2009 Dec,2011():1-11
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Chen-Yu Wangb)、(Rong-Chi Yang)、(Chih-Ju Chu)、(Hsiao-Ting Wu),Phyllanthus urinaria increases apoptosis and reduces telomerase activity in human nasopharyngeal carcinoma cells,FORSCHENDE KOMPLEMENTARMEDIZIN,2009 Feb,16(1):34-40
SCI論文 黃升騰(Huang, Sheng-Teng)、(Yashang Lee)、(Elizabeth A. Gullen)、(Yung-Chi Cheng)*,Impacts of baicalein analogs with modification of the 6th position of A ring on the activity toward NF-kappaB-, AP-1-, or CREB-mediated transcription,BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2008 Sep,18(18):5046-5049
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Gau-Yang Chen)、(Chien-Hui Wu)、(Cheng-Deng Kuo),Effect of disease activity and position on autonomic nervous modulation in patients with systemic lupus erythematosus,CLINICAL RHEUMATOLOGY,2008 Mar,27(3):295-300
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Annie Pei-Chun Chen),Traditional Chinese medicine and infertility,CURRENT OPINION IN OBSTETRICS & GYNECOLOGY,2008 ,20(3):211-215
SCI論文 黃升騰(Huang, Sheng-Teng)、(Rong-Chi Yang)、(Pei-Nir Lee)、(Su-Hui Yang)、(Shuen-Kuei Liao)、(Tzu-Ya Chen)、(Jong-Hwei S. Pang)*,Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma,INTERNATIONAL IMMUNOPHARMACOLOGY,2006 Jun,6(6):870-879
SCI論文 (Ching-Yuan Wu)、(Jong-Hwei S. Pang)、黃升騰(Huang, Sheng-Teng)*,Inhibition of melanogenesis in murine B16/F10 melanoma cells by Ligusticum sinensis Oliv,AMERICAN JOURNAL OF CHINESE MEDICINE,2006 ,34(3):523-533
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Gau-Yang Chen)、(Huey-Ming Lo)、林昭庚(Jaung-Geng Lin)、(Yin-Shiung Lee)、(Cheng-Deng Kuo),Increase in the vagal modulation by acupuncture at neiguan point in the healthy subjects,AMERICAN JOURNAL OF CHINESE MEDICINE,2005 ,33(1):157-164
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Rong-Chi Yang)、(Min-Yi Chen)、(Jong-Hwei S. Pang),Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptosis in HL-60 cells,LIFE SCIENCES,2004 Jun,75(3):339-351
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Rong-Chi Yang)、(Jong-Hwei S. Pang),Aqueous extract of Phyllanthus urinaria induces apoptosis in human cancer cells,AMERICAN JOURNAL OF CHINESE MEDICINE,2004 ,32(2):175-183
SCI論文 黃升騰(Huang, Sheng-Teng)*、(Rong-Chi Yang)、(Li-Jiun Yang)、(Pei-Nir Lee)、(Jong-Hwei S. Pang),Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells,LIFE SCIENCES,2003 Feb,72(15):1705-1716
 
研討會論文/Conference Papers
(發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
1﹒ Chinese herbal medicine to treat urolithiasis in a patient with right flank pain and hematuria: A case report,第19屆國際東洋醫學學術大會,National Taiwan University Hospital International Convention Center,2018.11.24 ~ 2018.11.26,
2﹒ Conventional treatment integrated with Chinese herbal medicine improves the survival of patients with advanced non-small cell lung cancer,第19屆國際東洋醫學學術大會,National Taiwan University Hospital International Convention Center,2018.11.24 ~ 2018.11.26,
3﹒ 中藥治療多發性硬化症患者IFN-β誘發的流感樣症狀: 個案報告,第八十八屆國醫節暨中醫治療運動傷害學術研討會,中國醫藥大學立夫教學大樓地下一樓國際會議廳(台中市北區學士路91號),2018.3.11 ~ 2018.3.11,
4﹒ 接受標靶治療的肺癌病患之中醫辨證分型研究,第88屆國醫節中醫治療運動傷害學術研討會,中國醫藥大學立夫教學大樓地下一樓國際會議廳,2018.3.11 ~ 2018.3.11,
5﹒ The Poor Appetite and Traditional Chinese Medicine:Qi Deficiency and Phlegm Dampness,10th European Public Health Conference,Stockholm,2017.11.1 ~ 2017.11.4,
 
研究計畫/Research Grant
(研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,研究經費,計畫期間)
1﹒ 個別型,M09G1036,黃升騰(Sheng-Teng Huang),林聖興(Sheng-Shing Lin)、黃維德(Wei-Te Huang)、林于娟(Ling yu chuan)、洪皓脩(Hao-Hsiu Hung)、歐世宸(Ou Shi Chen)、鄭惟仁(Wei-Zen Cheng)、陳昭憲(Chen Chao-Hsien)、黃鐙儀(HUANG TENG-I)、林宏恩(Lin Hung-En)、林亭延(Lin Ting yen),衛福部,建構智慧中醫及應用模式計畫,$3100000,2020.1.1 ~ 2020.12.15
2﹒ 個別型,MOHW108-CMAP-M-212-000103,黃升騰(Sheng-Teng Huang),孫茂峰(Mao-Feng Sun)、賴榮年(Jung-Nien Lai)、林嘉德(Chia-Der Lin)、邱德發(Te-Fa Chiu)、顏宏融(Hung-Rong Yen)、羅綸謙(Lun-Chien Lo)、張東?(Tung-Ti Chang)、林宏任(Hung-jen Lin)、李育臣(Yu-Chen Lee)、徐新政(Hsin-Cheng Hsu)、蘇珊玉(Shan-Yu Su)、黃國欽(Huang, Kuo-Chin)、林聖興(Sheng-Shing Lin)、黃敬軒(Ching-Hsuan Huang)、侯甫葦(Pu-Wei Hou)、蔡邱轔(Chiu-Lin Tsai)、吳旻峰(Min-Feng Wu)、涂慶業(Chin-Yeh Tu)、詹士賢(Shyh-Shyan Jan)、李雅玲(Ya-Ling Lee)、邱奕笙(Yi-Sheng Ciou)、陳暐棣(Wei-Di Chen)、洪瑞鴻(HUNG JUI-HUNG)、吳美瑤(Mei-Yao Wu)、何婧嫙(Ching-Hsuan Ho),衛福部,108年度「輔導中醫臨床技能評估模式及臨床教學實務訓練計畫」,$1450000,2019.1.25 ~ 2019.12.25
3﹒ 個別型,DMR-108-044,林聖興(Sheng-Shing Lin),黃升騰(Sheng-Teng Huang),附醫院內計畫,中醫大腸癌臨床醫案大數據分析,$300000,2018.8.1 ~ 2019.7.31
4﹒ 個別型,MOHW107-CMAP-M-211-000103,孫茂峰(Sun, Mao-Feng),張恒鴻(Chang, Hen-Hong)、林嘉德(Lin, Chia-Der)、方信元(Fang, Hsin-Yuan)、黃升騰(Huang, Sheng-Teng)、顏宏融(Yen, Hung-Rong)、張東?(Chang, Tung-Ti)、林宏任(Lin, Hung-Jen)、李育臣(Lee, Yu-Chen)、徐新政(Hsu, Hsin-Cheng)、蘇珊玉(Su, Shan-Yu)、黃國欽(Huang, kuo-Chin)、林聖興(Lin, Sheng-Shing)、侯甫葦(Pu-Wei Ho)、蔡邱轔(Chiu-Lin Tsai),衛福部,107年度「輔導中醫臨床技能評估模式及臨床教學實務訓練計畫」,$1300000,2018.1.25 ~ 2018.12.15
5﹒ 國家型,CMRC-CHM-0,顏宏融(Hung-Rong Yen),黃升騰(Sheng-Teng Huang)、李家琳(Chia-Lin Lee)、林振文(Lin Cheng Wen)、趙嶸(Chao, Jung)、湯智昕(Chih-Hsin Tang)、謝文聰、郭悅雄(Yueh-Hsiung Kuo)、郭盛助(Sheng-Chu kuo)、王陸海(Liu-Hai Wang)、佘玉萍(Yuh-Pyng Sher)、許游章(You-Cheng Hseu)、高銘欽(Ming-Ching Kao),教育部,中醫藥研究中心-中草藥研究群組,$10200000,2018.1.1 ~ 2018.12.31
6﹒ 個別型,DMR-107-006,黃升騰,附醫院內計畫,探討cryptotanshinone限制腫瘤之生長經抑制M2巨噬細胞分化並調控金屬蛋白酶及轉化生長因子-β表現以致抗血管新生,$500000,2017.8.1 ~ 2018.7.31
7﹒ 個別型,MOST 106-2320-B-039-026-,黃升騰(Huang, Sheng-Teng),科技部,丹參酮IIA抑制腫瘤效應:經由粒線體誘發細胞凋亡及經由抑制PI3K/Akt/mTOR逕路自噬反應之細胞及動物模型研究,$1135000,2017.8.1 ~ 2018.7.31
8﹒ 個別型,MOHW106-CMAP-M-211-000103,孫茂峰(SUN, MAO-FENG),張恒鴻(CHANG,HEN-HONG)、林嘉德(Chia-Der Lin)、方信元(Hsin-Yuan Fang)、黃升騰(Huang, Sheng-Teng)、顏宏融(Hung-Rong Yen)、張東?(Tung-Ti Chang)、林宏任(Lin Hung-jen)、李育臣(Yu-Chen Lee)、徐新政(Hsin-Cheng Hsu)、蘇珊玉(Shan-Yu Su)、黃國欽(kuo-Chin Huang)、侯甫葦(Pu-Wei Ho)、蔡邱轔(Chiu-Lin Tsai)、何婧嫙(Ching-Hsuan Ho),衛福部,輔導中醫臨床技能評估模式及教學實務訓練計畫,$1450000,2017.1.9 ~ 2017.12.15
9﹒ 個別型,106-2-N003,黃升騰(Huang, Sheng-Teng),夏德椿(Te-Chun Hsia)、林宏任(Lin Hung-jen)、何文照(Wen-Chao Ho)、王禎佑(WANG,CHEN-YU),衛福部,106年度「常見疾病之中醫證型研究」科技委託研幾究計畫,$1150000,2017.1.19 ~ 2018.1.18
10﹒ 國家型,NA,顏宏融(Hung-Rong Yen),謝慶良(Ching-Liang Hsieh)、林以文(Lin, Yi-Wen)、蘇冠賓(Kuan-Pin Su)、溫永銳(Yeong-Ray Wen)、陳易宏、李家琳(Chia-Lin Lee)、郭盛助(Sheng-Chu kuo)、佘玉萍(Yuh-Pyng Sher)、郭悅雄(Yueh-Hsiung Kuo)、許游章(You-Cheng Hseu)、林振文(Lin Cheng Wen)、黃升騰(Sheng-Teng Huang)、謝文聰、高銘欽(Ming-Ching Kao)、高尚德(Shung-Te Kao),教育部,中醫藥研究中心,$32354170,2017.1.1 ~ 2017.12.31
11﹒ 整合型(召集人、總主持人),1055918L,黃升騰(Huang, Sheng-Teng),高銘欽(Ming-Ching Kao)、周聖杰(Shen-Chieh Chou),本校(含附醫),校務準備金-PHY606為缺鐵性貧血的輔助藥物開發-子計畫一,$2000000,2016.12.1 ~ 2017.7.31
12﹒ 個別型,MOST 105-2320-B-039-035-,黃升騰(Huang, Sheng-Teng),張恒鴻、林祖功,科技部,隱丹參酮抑制腫瘤效應研究:經由調控粒線體動態條件改變及活化細胞凋亡與自噬反應,$800000,2016.8.1 ~ 2017.7.31
13﹒ 個別型,DMR-106-005,黃升騰(Huang, Sheng-Teng),張恒鴻(CHANG,HEN-HONG)、藍忠亮(Joung-Liang Lan),附醫院內計畫,柚皮苷在類風濕性關節炎上之抗發炎作用及可能機轉,$200000,2016.8.1 ~ 2017.7.31
14﹒ 個別型,採購案號:M05G9040,顏宏融(Hung-Rong Yen),黃秋錦(Chiu-Ching Huang)、孫茂峰(SUN, MAO-FENG)、張志宗(Chiz-Tzung Chang)、黃升騰(Huang, Sheng-Teng)、王怡寬(I-Kuan Wang)、黃國欽(kuo-Chin Huang)、郭慧亮(Huey-Liang kuo)、林宏任(Lin Hung-jen)、劉耀隆(Yao-Lung Liu)、李育臣(Yu-Chen Lee)、周哲毅(Che-Yi Chou)、丁羿文(I-Wen Ting)、楊雅斐(Ya-Fei Yang)、廖元敬(Yuan-Ching Liao)、李艾玲(Ai-Lin Lee)、楊潤(Jun Yang),衛福部,105年度「促進中醫多元發展」委託科技研究計劃,分項3:建構中醫日間照護模式計畫,$900000,2016.1.19 ~ 2016.12.15